PPARγ FL (human recombinant from E coli)

Stability : 6 months
Formulation :
A solution in 20 mM Tris HCl, pH 8.0, containing 250 mM KCl, 20% glycerol, 5 mM DTT, and 0.5 mM EDTA
Description :
PPARγ is the most widely studied and has been implicated in the pathology of numerous diseases including obesity, diabetes, atherosclerosis, and cancer. PPARγ is primarily expressed in adipose tissue and to a lesser extent in the colon, immune system, and the retina. The functionality of the DNA binding domain (DBD) was tested using PPARγ Transcription Factor Assay (Catalog no. 10006855). The purity was determined using gel electrophoresis followed by coomassie staining. The ligand binding domain functionality was confirmed using a fluorescent displacement assay with ANS and Rosiglitazone. 
Purity : >90% by SDS-PAGE
Storage : -80°C